Risk of Pneumococcal Disease in US Adults by Age and Risk Profile

Author:

Grant Lindsay R1ORCID,Meche Aster2,McGrath Leah2,Miles Amanda2,Alfred Tamuno3,Yan Qi1,Chilson Erica1

Affiliation:

1. Medical Development & Scientific/Clinical Affairs, Pfizer Vaccines , Collegeville, Pennsylvania , USA

2. Real World Evidence, Center of Excellence, Pfizer Inc , New York, New York , USA

3. Statistical Research and Data Science Center, Pfizer Inc , New York, New York , USA

Abstract

Abstract Background Older age and certain medical conditions are known to modify the risk of pneumococcal disease among adults. We quantified the risk of pneumococcal disease among adults with and without medical conditions in the United States between 2016 and 2019. Methods This retrospective cohort study used administrative health claims data from Optum's de-identified Clinformatics Data Mart Database. Incidence rates of pneumococcal disease—all-cause pneumonia, invasive pneumococcal disease (IPD), and pneumococcal pneumonia—were estimated by age group, risk profile (healthy, chronic, other, and immunocompromising medical condition), and individual medical condition. Rate ratios and 95% CIs were calculated comparing adults with risk conditions with age-stratified healthy counterparts. Results Among adults aged 18–49 years, 50–64 years, and ≥65 years, the rates of all-cause pneumonia per 100 000 patient-years were 953, 2679, and 6930, respectively. For the 3 age groups, the rate ratios of adults with any chronic medical condition vs healthy counterparts were 2.9 (95% CI, 2.8–2.9), 3.3 (95% CI, 3.2–3.3), and 3.2 (95% CI, 3.2–3.2), while the rate ratios of adults with any immunocompromising condition vs healthy counterparts were 4.2 (95% CI, 4.1–4.3), 5.8 (95% CI, 5.7–5.9), and 5.3 (95% CI, 5.3–5.4). Similar trends were observed for IPD and pneumococcal pneumonia. Persons with other medical conditions, such as obesity, obstructive sleep apnea, and neurologic disorders, were associated with increased risk of pneumococcal disease. Conclusions The risk of pneumococcal disease was high among older adults and adults with certain risk conditions, particularly immunocompromising conditions.

Funder

Pfizer Inc

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3